Since 2012, Biomeme has built its identity around decentralizing molecular diagnostics, developing field-ready testing for people who need biological answers outside a central laboratory. The Philadelphia company works with military and first-responder organizations as well as healthcare and research users, and makes its systems on site in a 40,000-square-foot vertically integrated facility.
CLIA-certified laboratory
Novel Microdevices, IncBaltimore-based Novel Microdevices develops portable, sample-to-answer molecular diagnostic systems built around disposable microfluidic cartridges. Its battery-powered Novel Dx platform is designed to deliver lab-quality PCR results in about 15 minutes, including testing for respiratory infections and other diseases at the point of care. The company is establishing a GMP-compliant pilot manufacturing facility at its Baltimore headquarters to scale cartridge production.BALTIMORE, MD
Prompt DiagnosticsBaltimore-based Prompt Diagnostics develops portable molecular diagnostic platforms that bring laboratory-quality PCR testing to the point of care, with results in under 20 minutes. Co-founded by biomedical engineer Alex Trick and Johns Hopkins professor Tza-Huei (Jeff) Wang, the company built its platform around magnetofluidic cartridge technology invented during Trick’s doctoral research. Prompt is applying that technology to infectious-disease testing, including work on HIV, syphilis, and drug-resistant gonorrhea in low-resource settings.BALTIMORE, MD
First Diagnostic CorporationFirst Diagnostic Corporation develops rapid point-of-care diagnostic systems and helps other medical-device manufacturers bring diagnostic technologies to the U.S. healthcare market. Founded in 2004 as a medical-device manufacturer, the privately held company now combines its own rapid-test brands with sales representation, distribution, marketing, and customer support for partner manufacturers. Its eight-person operation maintains government and military program relationships and cites GMP and ISO 9001 quality standards.NEW YORK, NY
Scanogen IncBaltimore-based Scanogen develops molecular diagnostic systems that detect infectious-disease biomolecules directly from body fluids, using its proprietary Single Molecule And Rapid Tethering (SMART) technology. The company is focused on a sample-to-answer platform for point-of-care testing, including an assay designed to identify bloodstream-infection pathogens from whole blood within two hours. Scanogen has received more than $20 million in NIH grants and collaborates with Johns Hopkins University and federal agencies in the Washington, D.C., area.BALTIMORE, MD